Kim CY - Search Results

1

Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer.

Paik S, Kim CY, Song YK, Kim WS. Paik S, et al. Among authors: kim cy, kim ws. Nat Clin Pract Oncol. 2005 May;2(5):246-54. doi: 10.1038/ncponc0171. Nat Clin Pract Oncol. 2005. PMID: 16264960 Review.

2

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N. Paik S, et al. N Engl J Med. 2004 Dec 30;351(27):2817-26. doi: 10.1056/NEJMoa041588. Epub 2004 Dec 10. N Engl J Med. 2004. PMID: 15591335 Free article. Clinical Trial.

3

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N. Paik S, et al. J Clin Oncol. 2006 Aug 10;24(23):3726-34. doi: 10.1200/JCO.2005.04.7985. Epub 2006 May 23. J Clin Oncol. 2006. PMID: 16720680 Corrected and republished.

4

HER2 status and benefit from adjuvant trastuzumab in breast cancer.

Paik S, Kim C, Wolmark N. Paik S, et al. N Engl J Med. 2008 Mar 27;358(13):1409-11. doi: 10.1056/NEJMc0801440. N Engl J Med. 2008. PMID: 18367751 No abstract available.

5

Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials.

Ross DT, Kim CY, Tang G, Bohn OL, Beck RA, Ring BZ, Seitz RS, Paik S, Costantino JP, Wolmark N. Ross DT, et al. Among authors: kim cy. Clin Cancer Res. 2008 Oct 15;14(20):6602-9. doi: 10.1158/1078-0432.CCR-08-0647. Clin Cancer Res. 2008. PMID: 18927301 Free PMC article. Clinical Trial.

6

Gene expression-based prognostic and predictive markers for breast cancer: a primer for practicing pathologists.

Kim C, Taniyama Y, Paik S. Kim C, et al. Arch Pathol Lab Med. 2009 Jun;133(6):855-9. doi: 10.5858/133.6.855. Arch Pathol Lab Med. 2009. PMID: 19492877 Free PMC article. Review.

7

Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.

Pusztai L, Jeong JH, Gong Y, Ross JS, Kim C, Paik S, Rouzier R, Andre F, Hortobagyi GN, Wolmark N, Symmans WF. Pusztai L, et al. J Clin Oncol. 2009 Sep 10;27(26):4287-92. doi: 10.1200/JCO.2008.21.6887. Epub 2009 Aug 10. J Clin Oncol. 2009. PMID: 19667268 Free PMC article.

8

Gene-expression-based prognostic assays for breast cancer.

Kim C, Paik S. Kim C, et al. Nat Rev Clin Oncol. 2010 Jun;7(6):340-7. doi: 10.1038/nrclinonc.2010.61. Epub 2010 May 4. Nat Rev Clin Oncol. 2010. PMID: 20440284 Review.

9

Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer.

Yang SX, Costantino JP, Kim C, Mamounas EP, Nguyen D, Jeong JH, Wolmark N, Kidwell K, Paik S, Swain SM. Yang SX, et al. J Clin Oncol. 2010 Jun 20;28(18):2974-81. doi: 10.1200/JCO.2009.26.1602. Epub 2010 May 17. J Clin Oncol. 2010. PMID: 20479407 Free PMC article. Clinical Trial.

10

Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.

Kim C, Tang G, Pogue-Geile KL, Costantino JP, Baehner FL, Baker J, Cronin MT, Watson D, Shak S, Bohn OL, Fumagalli D, Taniyama Y, Lee A, Reilly ML, Vogel VG, McCaskill-Stevens W, Ford LG, Geyer CE Jr, Wickerham DL, Wolmark N, Paik S. Kim C, et al. J Clin Oncol. 2011 Nov 1;29(31):4160-7. doi: 10.1200/JCO.2010.32.9615. Epub 2011 Sep 26. J Clin Oncol. 2011. PMID: 21947828 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,167 results

Search Page